Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Gujarat Themis Biosyn

Sector: Healthcare | Industry: Drugs & Pharma
R 44.85 -1.15  | -2.50% 34.89% 10.05 65.16
BSE Price: Oct 22, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 22, 2019 44.85 -1.15 -2.50% 45.00 46.00 20,784 44.20 - 45.50
NSE Feb 27, 2001 7.30 0.60 8.96% 7.30 6.70 1,750 7.25 - 7.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 3,215 P/B: 3.27 NSE Code: GUJTHEMIS
52-Week Range: R 28.15 - 52.10 Dividend Yield: 0.00% BSE Code: 506879
TTM EPS: R 4.46 Book Value: R 13.72 Face Value: R 5
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Gujarat Themis Biosyn 44.68 7.17 19.28 34.89 -9.74 18.92 18.51
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 5.80 7.96 6.31
Net Profit 65.73 11.45 7.21
EPS 65.73 11.45 7.20
Book Value 52.94 68.89 40.46
Average
Operating Margin 23.26 19.24 19.39
Net Margin 14.81 12.29 13.11
Return on Networth 41.85 50.85 91.05
Return on Investment 44.73 47.21 67.15
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 13.03 12.78 13.03
Operating Profit -31.47 18.80 -31.47
Net Profit -43.90 5.22 -43.90
EPS -43.86 5.29 -43.86
TTM
Revenue 3.23 6.75 3.23
Operating Profit 3.99 45.08 3.99
Net Profit 1.09 53.12 1.09
EPS 1.11 53.14 1.11
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Gujarat Themis Biosyn 65.16 42.38 6.48 14.34 41.85 3.27 10.05
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Aug 07, 2014 Pharmaceutical Business Group (India) Ltd.  Sell - 1,423,000 20.85 296.70
Jan 19, 2009 Themis Medicare Ltd  Buy Off Market 440,903 6.00 26.45
Dec 11, 2008 Gujarat Industrial Investment Corpn Ltd.  Sell Off Market 440,903 5.90 26.01
News & Announcements
Contact Information

Company: Gujarat Themis Biosyn Ltd.

Address: 69 / C, G I D C Industrial Estate, Vapi, Valsad Dist, Gujarat - 396195 | Phone: 0260-5544639,2432269,2426431,2430027 | Fax: 0260-2400638,2400639

Email: [email protected] / [email protected]

Website: www.gtbl.in

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
5.23
Piotroski F-Score
5
Modified C-Score
5
5-Years Price to Earnings
10.05
5-Years Price to Book
3.27
Earnings Yield
EBIT / Enterprise value
12.58%
PEG
Price / Earnings to growth ratio
1.70
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59